1Health Sciences Center, Department of Pathology, Stony Brook, New York 11794-7025, USA.
Measuring cell proliferation abnormalities is crucial for understanding cancer development and prognosis. Various techniques exist, but their limitations must be understood for reliable biomarker use in chemoprevention trials.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: